← Back to Search

Behavioral Intervention

Intervention for Lung Cancer (LUCARE Trial)

N/A

Recruiting

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-12 months

Awards & highlights

LUCARE Trial Summary

This trial aims to improve a lung cancer screening program in the Emergency Department by getting feedback from key people, testing the program, and understanding how people feel about it.

Who is the study for?

This trial is for individuals who may be at risk of lung cancer. The study aims to refine and test a new screening method called ED-LCS, which will be evaluated in the emergency department setting. Specific eligibility criteria are not provided.Check my eligibility

What is being tested?

The study is testing the Emergency Department Lung Cancer Screening (ED-LCS) intervention. It involves refining the screening process through interviews with stakeholders, pilot testing its effectiveness, acceptability, and feasibility, followed by an analysis of stakeholder experiences.See study design

What are the potential side effects?

Since this trial focuses on a screening intervention rather than a medical treatment or drug, there are no typical side effects associated with medications. However, any potential discomfort or risks related to the screening process itself have not been specified.

LUCARE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of patients receive Lung Cancer Screening

Secondary outcome measures

Patients ratings of intervention

LUCARE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Patients will be shown a modified version of LungTalk.

Group II: Usual CareActive Control1 Intervention

Patients will receive usual care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Eskenazi HealthOTHER

11 Previous Clinical Trials

2,690 Total Patients Enrolled

Indiana UniversityLead Sponsor

980 Previous Clinical Trials

981,618 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be a participant in this clinical trial?

"To be eligible for enrollment, patients must have a diagnosis of lung carcinoma and fall between the ages of 50 to 80. The trial has capacity for up to 144 participants."

Answered by AI

Are individuals who are above the age of 60 eligible to participate in this medical study?

"Participants eligible for this research must fall within the age range of 50 to 80 years old. Notably, there are numerous clinical trials available for individuals below 18 and over 65 years of age, with a total of 35 trials catering to the former group and a substantial number of 1629 trials focusing on the latter age bracket."

Answered by AI

What is the current number of individuals receiving treatment within this specific clinical trial?

"Indeed, the details available on clinicaltrials.gov highlight that this medical investigation is presently seeking suitable candidates. The trial was initially published on December 1st, 2023, and last revised on April 8th, 2024. A total of 144 individuals are sought across a single designated site."

Answered by AI

Are there any ongoing efforts to enroll participants for this study at the moment?

"The details on clinicaltrials.gov reveal that this trial is presently in search of subjects. The initial posting was on December 1st, 2023, with the latest update made on April 8th, 2024. Enrollment is open for 144 participants at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Increasing Equity in Lung Cancer Screening

Nicholas Pettit 2023. "Increasing Equity in Lung Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06360822.

All > Cincinnati > Indianapolis